Clinical outcomes following identification of an incidental p53 signature in the fallopian tube
Fallopian tube pathology in patients with BRCA1 and BRCA2 mutations suggests a possible pathway to high grade serous ovarian carcinoma originates with a p53 signature, which is thought to represent a potential precursor to serous tubal intraepithelial carcinoma (STIC).The clinical implications of an isolated Collections p53 signature in the average